Literature DB >> 15691896

Decreased expression of e6-associated protein in breast and prostate carcinomas.

Xiuhua Gao1, Syed K Mohsin, Zoran Gatalica, Guilian Fu, Poonam Sharma, Zafar Nawaz.   

Abstract

The E6-associated protein (E6-AP) is a dual function protein. It acts as an E3 ubiquitin-protein ligase as well as a steroid hormone receptor coactivator. Considering the influence of steroid hormone receptors and their coactivators in the normal development and tumorigenesis of reproductive organs of both genders, we examined the roles of E6-AP in the tumorigenesis of breast and prostate tissues. We demonstrated that the expression of E6-AP protein is decreased in human invasive breast and prostate carcinomas compared with their adjacent normal tissues, and this down-regulation of E6-AP is accompanied by the up-regulation of estrogen receptor (ER)-alpha in breast and androgen receptor (AR) in prostate carcinomas. Furthermore, our in vivo data from E6-AP-knockout animals indicated that the expression levels of ERalpha and AR are increased in E6-AP-null mammary and prostate glands, respectively, when compared with that of normal control animals, suggesting that E6-AP modulates the protein levels of ERalpha in breast and AR in prostate glands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691896     DOI: 10.1210/en.2004-1198

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice.

Authors:  Anny Shai; Henry C Pitot; Paul F Lambert
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.

Authors:  P Rajbhandari; K A Schalper; N M Solodin; S J Ellison-Zelski; K Ping Lu; D L Rimm; E T Alarid
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

Review 3.  Ubiquitylation of nuclear receptors: new linkages and therapeutic implications.

Authors:  Kyle T Helzer; Christopher Hooper; Shigeki Miyamoto; Elaine T Alarid
Journal:  J Mol Endocrinol       Date:  2015-05-05       Impact factor: 5.098

4.  E6AP in the brain: one protein, dual function, multiple diseases.

Authors:  Jimmy El Hokayem; Zafar Nawaz
Journal:  Mol Neurobiol       Date:  2013-10-05       Impact factor: 5.590

5.  Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.

Authors:  S Sarkar; D L Brautigan; S J Parsons; J M Larner
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

Review 6.  Who's in charge? Nuclear receptor coactivator and corepressor function in brain and behavior.

Authors:  Marc J Tetel; Anthony P Auger; Thierry D Charlier
Journal:  Front Neuroendocrinol       Date:  2009-05-04       Impact factor: 8.606

7.  Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor beta.

Authors:  Nathalie Picard; Catherine Charbonneau; Mélanie Sanchez; Anne Licznar; Muriel Busson; Gwendal Lazennec; André Tremblay
Journal:  Mol Endocrinol       Date:  2007-10-25

Review 8.  Derailed estrogen signaling and breast cancer: an authentic couple.

Authors:  Bramanandam Manavathi; Oindrilla Dey; Vijay Narsihma Reddy Gajulapalli; Raghavendra Singh Bhatia; Suresh Bugide; Rakesh Kumar
Journal:  Endocr Rev       Date:  2012-09-04       Impact factor: 19.871

9.  Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4.

Authors:  Yan Xie; Dennis W Wolff; Taotao Wei; Bo Wang; Caishu Deng; Joseph K Kirui; Haihong Jiang; Jianbing Qin; Peter W Abel; Yaping Tu
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

Review 10.  Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression.

Authors:  Katherine M Scarpin; J Dinny Graham; Patricia A Mote; Christine L Clarke
Journal:  Nucl Recept Signal       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.